Diversification into preventative and at-home healthcare, digital innovation, and younger customer segments is strengthening Medibank's market position and supporting sustained top-line growth. The company provides virtual health, homecare, preventative health and primary care services through its Amplar Health Division, which supports the core insurance business.
Cyborg Score Rationale
FY2025 revenue grew 6.56% to $8.56B while earnings increased 1.69% to $500.80M. Market position remains strong but elevated premium growth environment and regulatory pressures create headwinds.
Top Insights
Policyholder growth accelerated to 1.4% over the last 12 months, double the prior year rate
2026 faces industry-wide premium increases of 4-5%, the largest rise in a decade, potentially adding $105-132 annually to average hospital policies
Robust M&A strategy and industry consolidation trends are increasing revenue diversity and providing significant long-term earnings potential
Potential regulatory changes to private hospital pricing could add $800M-$1.2B annually to healthcare costs, impacting margins and member participation
Named Competitors
Bupa — Second-largest Australian private health insurer with $7.97B premium revenue
NIB Holdings — Australia's fourth-largest listed health fund
HCF — Unlisted health insurer with $4.12B in premium income
ahm — Medibank-owned brand covering 1.2M+ members
Recent Developments
(Feb 2026) Next earnings date scheduled for Feb 18, 2026
(Jan 2026) New member acquisition promotions launched including 10 weeks free premium offer
(2025) Dividend maintained at approximately 10.2c per share with 3.9% yield
Open the full interactive Medibank Private Limited report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.